Family · Pharmaceutical analytical standards
Bisoprolol
A beta-blocker highly selective for the heart's beta-1 receptors, patented in 1976 and approved in 1986; it is used for hypertension, angina and heart failure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?For years beta-blockers were thought best avoided in heart failure: the CIBIS-II trial, published in 1999, showed that bisoprolol cut mortality by about a third.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
